Perceptic raises $12m seed round to build unified AI platform for drug development
By
Kirstie Pickering
Crackles when you bite it. Shows the baker did the work.
Summary
Perceptic has raised $12m (£9m) in seed funding led by Accel, Air Street Capital, and Elder Gull to develop a unified AI system that integrates research, development, and clinical decision-making across the entire drug lifecycle. The company aims to address the fragmented nature of drug development, where proprietary data and institutional knowledge are siloed across incompatible systems. While AI has been applied to pharma before, Perceptic's approach focuses on creating a single, cohesive platform rather than individual tools or models.
Key quotes
· 2 pulledDrug development remains a complex and labor-intensive process, with decades of proprietary data, decisions and institutional knowledge kept within systems that were never designed to talk to each other.
Despite advances in frontier research, AI transformation approaches in pharma to date have primarily focused on building better tools or models to improve individual...
You might also wanna read
Perspective AI: A Powerful AI Research Platform for Teams
Perspective AI is introduced as the world's most powerful AI research platform, designed for product, marketing, research, and CX teams. It
Product Hunt·10mo ago
Google DeepMind CEO claims goal of "solving all disease" through AI drug discovery
This special early edition of The Verge's Optimizer newsletter, tied to Google I/O coverage, contextualizes a bold claim made by Google Deep
The Verge·11d ago